Efficacy and Safety of a Urate Lowering Regimen in Primary Gout

Author： Bailén Rebeca González Senac Nicolás M. López Mónica M. Llena M. Luisa Migoya Marta Rodríguez M. Teresa de Miguel Eugenio Torres Rosa J. Puig Juan G.

Publisher： Taylor & Francis Ltd

ISSN： 1525-7770

Source： Nucleosides, Nucleotides & Nucleic Acids, Vol.33, Iss.4-6, 2014-04, pp. : 174-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Determinants of the Clinical Outcomes of Gout During the First Year of Urate-Lowering Therapy

By Becker Michael MacDonald Patricia Hunt Barbara Lademacher Christopher Joseph-Ridge Nancy

Nucleosides, Nucleotides & Nucleic Acids, Vol. 27, Iss. 6-7, 2008-06 ,pp. : 585-591

Taylor & Francis Ltd

Access to resources Recommend Favorite

Metabolic Syndrome in Primary Gout

By González-Senac Nicolás M. Bailén Rebeca Torres Rosa J. de Miguel Eugenio Puig Juan G.

Nucleosides, Nucleotides & Nucleic Acids, Vol. 33, Iss. 4-6, 2014-04 ,pp. : 185-191

Taylor & Francis Ltd

Access to resources Recommend Favorite

The efficacy and safety of golimumab in the treatment of arthritis

By Fleischmann Roy

Expert Opinion on Biological Therapy, Vol. 10, Iss. 7, 2010-07 ,pp. : 1131-1143

Informa Healthcare

Access to resources Recommend Favorite

Application of population pharmacokinetics for preclinical safety and efficacy studies

By Porzio Stefano

Bioanalysis, Vol. 5, Iss. 16, 2013-08 ,pp. : 2053-2069

Future Science

Access to resources Recommend Favorite

The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis

By Fleischmann Roy

Expert Opinion on Biological Therapy, Vol. 10, Iss. 5, 2010-05 ,pp. : 773-786

Informa Healthcare

Access to resources Recommend Favorite